Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7284
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. It is advancing a preclinical and clinical stage product pipeline to fight cancers of the cervix, prostate, breast, bladder, head and neck, lung, and pancreas; and to protect against and eliminate infectious diseases such as HIV, hepatitis, Ebola, Zika virus and Middle East respiratory syndrome (MERS). Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc (INO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Equity Offering 11
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 11
Inovio Pharma Raises USD75 Million in Public Offering of Shares 12
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 14
Inovio Pharmaceuticals Inc – Key Competitors 15
Inovio Pharmaceuticals Inc – Key Employees 16
Inovio Pharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 07, 2018: Inovio Pharmaceuticals reports 2018 second quarter financial results 19
May 09, 2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results 21
Mar 14, 2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results 23
Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 26
May 10, 2017: Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results 29
Mar 15, 2017: Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results 31
Corporate Communications 34
May 24, 2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D 34
Dec 06, 2017: Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors 35
Jun 28, 2017: Inovio Announces Leadership Appointments 36
Mar 21, 2017: George Bickerstaff Elected to Inovio’s Board of Directors 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Inovio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 11
Inovio Pharma Raises USD75 Million in Public Offering of Shares 12
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 14
Inovio Pharmaceuticals Inc, Key Competitors 15
Inovio Pharmaceuticals Inc, Key Employees 16
Inovio Pharmaceuticals Inc, Subsidiaries 18

List of Figures
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • BASF SE (BAS)-製薬・医療分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Premaitha Health Plc (NIPT):企業の財務・戦略的SWOT分析
    Premaitha Health Plc (NIPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Serco Group plc:企業の戦略・SWOT・財務情報
    Serco Group plc - Strategy, SWOT and Corporate Finance Report Summary Serco Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Samsung Electronics Co., Ltd.:企業の戦略・SWOT・財務情報
    Samsung Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …
  • Nippon Shokubai Co Ltd (4114):企業の財務・戦略的SWOT分析
    Nippon Shokubai Co Ltd (4114) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pulse Seismic Inc (PSD):企業の財務・戦略的SWOT分析
    Summary Pulse Seismic Inc (Pulse), formerly Pulse Data Inc is a provider of seismic data library for oil and gas exploration. The company acquires, markets and licenses 2D and 3D seismic data to the western Canadian energy sector. It offers services such as project cost tracking, scouting, geophysic …
  • Qc Holdings Inc
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • 84 Lumber Company:企業の戦略・SWOT・財務情報
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Forum Energy Technologies Inc:企業の戦略・SWOT・財務情報
    Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Samyang Holdings Corp (000070):企業の財務・戦略的SWOT分析
    Summary Samyang Holdings Corp (Samyang) is a holding company engaged in the development and manufacture of food, pharmaceutical and chemical products. The company produces chemicals such as terephthalic acid, engineering plastics, organic chemicals, resins and other specialty chemicals; food materia …
  • Endeavour Mining Corporation:企業のM&A・事業提携・投資動向
    Endeavour Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endeavour Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Bastide Le Confort Medical SA (BLC)-医療機器分野:企業M&A・提携分析
    Summary Bastide Le Confort Medical SA (Bastide Le) is a medical equipment company that provides personal care products. The company offers medical devices for individuals and home health care professionals. It provides products such as lift chairs and accessories, pillows, cushions and special seati …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Mitsubishi Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Addex Therapeutics Ltd (ADXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company’s product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson’s disease levodopa-induced dy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆